デフォルト表紙
市場調査レポート
商品コード
1746491

日本のプロテオミクス市場レポート:分析タイプ、コンポーネントタイプ、技術、用途、エンドユーザー、地域別、2025~2033年

Japan Proteomics Market Report by Analysis Type, Component Type, Technology, Application, End User (Clinical Diagnostic Laboratories, Research Organizations, and Others), and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 120 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
日本のプロテオミクス市場レポート:分析タイプ、コンポーネントタイプ、技術、用途、エンドユーザー、地域別、2025~2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 120 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のプロテオミクス市場規模は2024年に26億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに116億米ドルに達し、2025~2033年にかけて16.7%の成長率(CAGR)を示すと予測しています。政府機関による新薬開発への投資の増加が、主に市場成長の原動力となっています。

本レポートで扱う主要質問

  • 日本のプロテオミクス市場はこれまでどのように推移し、今後どのように推移するのか?
  • COVID-19が日本のプロテオミクス市場に与えた影響は?
  • 日本のプロテオミクス市場の分析タイプ別区分は?
  • 日本のプロテオミクス市場のコンポーネントタイプ別区分は?
  • 日本のプロテオミクス市場を技術別区分は?
  • 日本のプロテオミクス市場の用途別区分は?
  • 日本のプロテオミクス市場のエンドユーザー別区分は?
  • 日本のプロテオミクス市場のバリューチェーンにおける様々なステージとは?
  • 日本のプロテオミクスの主要な促進要因と課題は何か?
  • 日本のプロテオミクス市場の構造と主要参入企業は?
  • 日本のプロテオミクス市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 プロテオミクス市場-イントロダクション

  • 概要
  • 市場力学
  • 産業動向
  • 競合情報

第5章 プロテオミクス市場情勢

  • 過去と現在の市場動向(2019~2024年)
  • 市場予測(2025~2033年)

第6章 プロテオミクス市場-分析タイプ別内訳

  • 構造的プロテオミクス
  • 機能的プロテオミクス
  • タンパク質発現プロテオミクス

第7章 プロテオミクス市場-コンポーネントタイプ別内訳

  • コアプロテオミクスサービス
  • バイオインフォマティクスソフトウェアと関連サービス

第8章 プロテオミクス市場-技術別内訳

  • 分光法
  • クロマトグラフィー
  • 電気泳動
  • タンパク質マイクロアレイ
  • X線結晶構造分析
  • 表面プラズモン共鳴
  • その他

第9章 プロテオミクス市場-用途別内訳

  • タンパク質発現プロファイリング
  • プロテオームマイニング
  • 翻訳後修飾

第10章 プロテオミクス市場-エンドユーザー別内訳

  • 臨床診断ラボ
  • 研究機関(創薬)
  • その他

第11章 プロテオミクス市場-競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第12章 主要企業のプロファイル

第13章 プロテオミクス市場-産業分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第14章 付録

目次
Product Code: SR112025A18329

Japan proteomics market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.6 Billion by 2033, exhibiting a growth rate (CAGR) of 16.7% during 2025-2033. The increasing investments by government bodies in the development of novel drugs are primarily driving the market growth.

Proteomics is the comprehensive study of proteins, encompassing their structures and functions. It delves into how proteins change and adapt under different circumstances. The field investigates the presence and configurations of proteins in both their functional and non-functional states, aiming to discern their specific roles and interactions with other proteins. To achieve this, a range of sophisticated technologies are employed in tandem with proteomics to pinpoint and quantify proteins, as well as to identify potential diagnostic indicators. Additionally, proteomics evaluates the pace at which proteins are produced and maps out their interaction networks. Given these capabilities, proteomics plays a crucial role in advancing drug research and tailoring medicines to individual needs.

Japan Proteomics Market Trends:

In the context of the Japan market, the increasing inclination towards personalized medicine is significantly propelling market growth. This surge is complemented by consistent advancements in biotechnology and drug discovery. Proteomic systems, when implemented, streamline the drug discovery process, becoming integral to the chemical formulation and biological evaluation of multiple medicines. Additionally, Japan's cutting-edge technology and robust research and development (R&D) infrastructure have enabled a nuanced analysis of proteins. This detailed analysis plays a pivotal role in devising cancer treatments, marking a substantial growth factor for the market. The enhancement of Japan's healthcare framework, combined with supportive government policies advocating for research and the discovery of new drugs, further bolsters this upward market trend. Moreover, the market is propelled by the growing integration of technology in detailed protein analysis methods. These methods encompass techniques like Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems, and X-ray crystallography. Such innovations facilitate an in-depth quantitative and qualitative examination of proteins, aiding in the determination of cancer treatments. Furthermore, regulations by government bodies that promote widespread research and development (R&D) activities are expected to fuel the regional market in the coming years.

Japan Proteomics Market Segmentation:

Analysis Type Insights:

  • Structural Proteomics
  • Functional Proteomics
  • Protein Expression Proteomics

Component Type Insights:

  • Core Proteomics Services
  • Bioinformatics Software and Related Services

Technology Insights:

  • Spectroscopy
  • Chromatography
  • Electrophoresis
  • Protein Microarrays
  • X-Ray Crystallography
  • Surface Plasmon Resonance
  • Others

Application Insights:

  • Protein Expression Profiling
  • Proteome Mining
  • Post-Translational Modifications

End User Insights:

  • Clinical Diagnostic Laboratories
  • Research Organizations (Drug Discovery)
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan proteomics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan proteomics market?
  • What is the breakup of the Japan proteomics market on the basis of analysis type?
  • What is the breakup of the Japan proteomics market on the basis of component type?
  • What is the breakup of the Japan proteomics market on the basis of technology?
  • What is the breakup of the Japan proteomics market on the basis of application?
  • What is the breakup of the Japan proteomics market on the basis of end user?
  • What are the various stages in the value chain of the Japan proteomics market?
  • What are the key driving factors and challenges in the Japan proteomics?
  • What is the structure of the Japan proteomics market and who are the key players?
  • What is the degree of competition in the Japan proteomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Proteomics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Proteomics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Proteomics Market - Breakup by Analysis Type

  • 6.1 Structural Proteomics
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Functional Proteomics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Protein Expression Proteomics
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)

7 Japan Proteomics Market - Breakup by Component Type

  • 7.1 Core Proteomics Services
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Bioinformatics Software and Related Services
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Proteomics Market - Breakup by Technology

  • 8.1 Spectroscopy
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Chromatography
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Electrophoresis
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Protein Microarrays
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 X-Ray Crystallography
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2019-2024)
    • 8.5.3 Market Forecast (2025-2033)
  • 8.6 Surface Plasmon Resonance
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2019-2024)
    • 8.6.3 Market Forecast (2025-2033)
  • 8.7 Others
    • 8.7.1 Historical and Current Market Trends (2019-2024)
    • 8.7.2 Market Forecast (2025-2033)

9 Japan Proteomics Market - Breakup by Application

  • 9.1 Protein Expression Profiling
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Proteome Mining
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Post-Translational Modifications
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)

10 Japan Proteomics Market - Breakup by End User

  • 10.1 Clinical Diagnostic Laboratories
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Research Organizations (Drug Discovery)
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Others
    • 10.3.1 Historical and Current Market Trends (2019-2024)
    • 10.3.2 Market Forecast (2025-2033)

11 Japan Proteomics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Proteomics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix